Several studies have shown higher platelet activation levels in β-thalassemia intermedia and splenectomized thalassemia patients than in healthy volunteers8,10–14, and previous studies have indicated that the CD62P (P selectin) is a reliable marker for measuring platelet activation15. The gene discussed is SELP; the disease is thalassemia.